Evidence map›Paper›PMID 41385086›Full record

ArticleWiener klinische Wochenschrift2026

Performance of the automated DNA extraction with MagNA Pure 24 for further genetic testing for hemoglobinopathies with Globin StripAssays.

Georg Leixner, Astrid Voill-Glaninger, Julia Gaugeler-Kurzweil, Tanja Kusstatscher, Tanja Panic-Jankovic, Wolfgang Novak, Leo Kager, Christian Oberkanins, André Viveiros

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Wiener klinische Wochenschrift, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Georg LeixnerInstitute for Laboratory Medicine, Klinik Landstrasse, Vienna Healthcare Group, Juchgasse 25, 1030, Vienna, Austria.
Astrid Voill-GlaningerInstitute for Laboratory Medicine, Klinik Landstrasse, Vienna Healthcare Group, Juchgasse 25, 1030, Vienna, Austria.
Julia Gaugeler-KurzweilInstitute for Laboratory Medicine, Klinik Landstrasse, Vienna Healthcare Group, Juchgasse 25, 1030, Vienna, Austria.
Tanja KusstatscherInstitute for Laboratory Medicine, Klinik Landstrasse, Vienna Healthcare Group, Juchgasse 25, 1030, Vienna, Austria.
Tanja Panic-JankovicInstitute for Laboratory Medicine, Klinik Landstrasse, Vienna Healthcare Group, Juchgasse 25, 1030, Vienna, Austria.
Wolfgang NovakDepartment of Pediatrics and Medical University Vienna Children's Cancer Research Institute, St. Anna Children's Hospital, Vienna, Austria.
Leo KagerDepartment of Pediatrics and Medical University Vienna Children's Cancer Research Institute, St. Anna Children's Hospital, Vienna, Austria.
Christian OberkaninsViennaLab Diagnostics GmbH, Gauzendorfer Gürtel 43-45, 1120, Vienna, Austria.
André ViveirosInstitute for Laboratory Medicine, Klinik Landstrasse, Vienna Healthcare Group, Juchgasse 25, 1030, Vienna, Austria. andre.viveiros@gesundheitsverbund.at.ORCID http://orcid.org/0000-0001-7141-8867

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDiagnosing hemoglobinopathies through reverse hybridization with Globin StripAssays (ViennaLab, Vienna, Austria) is widely performed. There are only two authorized hands-on DNA extraction methods for these assays: the spin Micro DNA Extraction Kit (ViennaLab, Vienna, Austria) for the α‑Globin StripAssay and GEN

methodsWe analyzed blood samples of 41 patients with clinical suspicion of hemoglobinopathies. As the gold standard we stipulated the ViennaLab DNA extraction methods and compared them to the MagNA Pure 24 Total Isolation Kit performed on MagNA Pure. The results of the different test strips were qualitatively classified with respect to good and weak read outs, background signals as well as true/false positives or negatives.

resultsA total of 6226 StripAssay lines were analyzed. After extraction with the gold standard 98.3% had a good read out, 0.9% a weak read out and in 0.9% a background signal was identified. After extraction with MagNA Pure 99.4% had a good read out, 0.2% a weak read out and a background signal was found in only 0.5% of the lines (P < 0.001) and there were no false positives or negatives (sensitivity and specificity 100.0%).

conclusionThe automated DNA extraction with MagNa Pure showed noninferior results when compared with the Spin Micro and GEN

Indexed as

beta-GlobinsDNAGenetic TestingHemoglobinopathiesalpha-Globinsbeta-ThalassemiaHumansReagent Kits, DiagnosticSensitivity and Specificityalpha-Globinsbeta-GlobinsDNAReagent Kits, DiagnosticAlpha-thalassemiaBeta-thalassemiaHemoglobin genesHemoglobin variantsViennaLab

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.